Liabilities, Current of Maze Therapeutics, Inc. from 31 Dec 2024 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
- Summary
-
Maze Therapeutics, Inc. quarterly Liabilities, Current in USD history and change rate from 31 Dec 2024 to 31 Dec 2025.
- Maze Therapeutics, Inc. Liabilities, Current for the quarter ending 31 Dec 2025 was $22,556,000, a 9.1% increase year-over-year.
- Source SEC data
- View on sec.gov
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)
Maze Therapeutics, Inc. Quarterly Liabilities, Current (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $22,556,000 | +$1,883,000 | +9.1% | 31 Dec 2025 | 10-K | 25 Mar 2026 | 2025 | FY |
| Q3 2025 | $22,112,000 | 30 Sep 2025 | 10-Q | 06 Nov 2025 | 2025 | Q3 | ||
| Q2 2025 | $19,900,000 | 30 Jun 2025 | 10-Q | 12 Aug 2025 | 2025 | Q2 | ||
| Q1 2025 | $18,617,000 | 31 Mar 2025 | 10-Q | 14 May 2025 | 2025 | Q1 | ||
| Q4 2024 | $20,673,000 | 31 Dec 2024 | 10-K | 25 Mar 2026 | 2025 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.